Market Tracker

10/31 1:49pm ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

28.02
Real-Time Quote
 -0.03 / -0.11%
Today’s Change
15.64
Today|||52-Week Range
32.00
+12.12%
Year-to-Date

Today’s Trading

Previous close28.05
Today’s open28.75
Day’s range27.82 - 28.95
Volume804,370
Average volume (3 months)1,217,700
Market cap$2.8B
Dividend yield--
Data as of 1:34pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)-15.79%
Earnings growth (this year)-96.21%
Earnings growth (next 5 years)--
Revenue growth (last year)-76.67%
P/E ratioNM
Price/Sales1,870.76
Price/Book14.03

Competitors

 Today’s
change
Today’s
% change
RCPTReceptos Inc+2.15+2.11%
MYGNMyriad Genetics Inc+0.83+2.18%
WXWuxi Pharmatech Caym...+0.14+0.37%
--Cosmo Pharmaceutical...-11.95-6.38%
Data as of 1:46pm ET, 10/31/2014

Financials

Next reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$1.1M
Annual profit (last year)-$37.9M
Net profit margin-3,314.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
CAO
Uli Hacksell
Executive VP, Chief Financial &
Business Officer
Stephen R. Davis
Corporate headquarters
San Diego, California

Forecasts